Modulation by sphingolipids of calcium signals evoked by epidermal growth factor
Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma A431 cells, sphingosine (1-10 microM) by it...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 1994-08, Vol.269 (34), p.21885-21890 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 21890 |
---|---|
container_issue | 34 |
container_start_page | 21885 |
container_title | The Journal of biological chemistry |
container_volume | 269 |
creator | Hudson, P L Pedersen, W A Saltsman, W S Liscovitch, M MacLaughlin, D T Donahoe, P K Blusztajn, J K |
description | Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing
putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma
A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet
within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter
Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to
sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine
(10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations
in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine,
sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations
of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine
immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine
content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein
was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with
both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may
constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation
of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects. |
doi_str_mv | 10.1016/S0021-9258(17)31885-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76675207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76675207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</originalsourceid><addsrcrecordid>eNqFkMFu1DAQhq0KVLalj1ApB4ToIeCxY8c-ogpopVYgFSRulmOPN4ZkvdgJVd--2e6q185lDvP9M6OPkHOgH4GC_HRHKYNaM6E-QHvBQSlR6yOyAqp4zQX8fkVWz8gbclLKH7pUo-GYHCsqueJ8RX7cJj8PdoppU3UPVdn2cbNOQ9xGX6oUKmcHF-exKnG9sUOp8H_6i36H4oJgHu1QrXO6n_oqWDel_Ja8DguIZ4d-Sn59_fLz8qq--f7t-vLzTe0agKlGKajW3obOCYrMg_AKpfQhNJ4H6VvlnWRWM88bdKA9WInLz6KTygVU_JS83-_d5vRvxjKZMRaHw2A3mOZiWilbwWj7IghSMqlYs4BiD7qcSskYzDbH0eYHA9TslJsn5Wbn00BrnpQbveTODwfmbkT_nDo4Xubv9vM-rvv7mNF0MbkeR8OkNrwxbLeIPwJxSImq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16626824</pqid></control><display><type>article</type><title>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Hudson, P L ; Pedersen, W A ; Saltsman, W S ; Liscovitch, M ; MacLaughlin, D T ; Donahoe, P K ; Blusztajn, J K</creator><creatorcontrib>Hudson, P L ; Pedersen, W A ; Saltsman, W S ; Liscovitch, M ; MacLaughlin, D T ; Donahoe, P K ; Blusztajn, J K</creatorcontrib><description>Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing
putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma
A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet
within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter
Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to
sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine
(10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations
in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine,
sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations
of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine
immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine
content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein
was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with
both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may
constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation
of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1016/S0021-9258(17)31885-9</identifier><identifier>PMID: 8063833</identifier><language>eng</language><publisher>United States: American Society for Biochemistry and Molecular Biology</publisher><subject>Calcium - metabolism ; Carcinoma, Squamous Cell - metabolism ; Epidermal Growth Factor - pharmacology ; Humans ; Phosphorylation ; Protein-Serine-Threonine Kinases - metabolism ; Protein-Tyrosine Kinases - metabolism ; Second Messenger Systems - drug effects ; Sphingolipids - pharmacology ; Sphingosine - pharmacology ; Tumor Cells, Cultured</subject><ispartof>The Journal of biological chemistry, 1994-08, Vol.269 (34), p.21885-21890</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</citedby><cites>FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8063833$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hudson, P L</creatorcontrib><creatorcontrib>Pedersen, W A</creatorcontrib><creatorcontrib>Saltsman, W S</creatorcontrib><creatorcontrib>Liscovitch, M</creatorcontrib><creatorcontrib>MacLaughlin, D T</creatorcontrib><creatorcontrib>Donahoe, P K</creatorcontrib><creatorcontrib>Blusztajn, J K</creatorcontrib><title>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing
putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma
A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet
within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter
Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to
sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine
(10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations
in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine,
sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations
of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine
immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine
content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein
was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with
both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may
constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation
of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects.</description><subject>Calcium - metabolism</subject><subject>Carcinoma, Squamous Cell - metabolism</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Humans</subject><subject>Phosphorylation</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Second Messenger Systems - drug effects</subject><subject>Sphingolipids - pharmacology</subject><subject>Sphingosine - pharmacology</subject><subject>Tumor Cells, Cultured</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFu1DAQhq0KVLalj1ApB4ToIeCxY8c-ogpopVYgFSRulmOPN4ZkvdgJVd--2e6q185lDvP9M6OPkHOgH4GC_HRHKYNaM6E-QHvBQSlR6yOyAqp4zQX8fkVWz8gbclLKH7pUo-GYHCsqueJ8RX7cJj8PdoppU3UPVdn2cbNOQ9xGX6oUKmcHF-exKnG9sUOp8H_6i36H4oJgHu1QrXO6n_oqWDel_Ja8DguIZ4d-Sn59_fLz8qq--f7t-vLzTe0agKlGKajW3obOCYrMg_AKpfQhNJ4H6VvlnWRWM88bdKA9WInLz6KTygVU_JS83-_d5vRvxjKZMRaHw2A3mOZiWilbwWj7IghSMqlYs4BiD7qcSskYzDbH0eYHA9TslJsn5Wbn00BrnpQbveTODwfmbkT_nDo4Xubv9vM-rvv7mNF0MbkeR8OkNrwxbLeIPwJxSImq</recordid><startdate>19940826</startdate><enddate>19940826</enddate><creator>Hudson, P L</creator><creator>Pedersen, W A</creator><creator>Saltsman, W S</creator><creator>Liscovitch, M</creator><creator>MacLaughlin, D T</creator><creator>Donahoe, P K</creator><creator>Blusztajn, J K</creator><general>American Society for Biochemistry and Molecular Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19940826</creationdate><title>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</title><author>Hudson, P L ; Pedersen, W A ; Saltsman, W S ; Liscovitch, M ; MacLaughlin, D T ; Donahoe, P K ; Blusztajn, J K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Calcium - metabolism</topic><topic>Carcinoma, Squamous Cell - metabolism</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Humans</topic><topic>Phosphorylation</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Second Messenger Systems - drug effects</topic><topic>Sphingolipids - pharmacology</topic><topic>Sphingosine - pharmacology</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hudson, P L</creatorcontrib><creatorcontrib>Pedersen, W A</creatorcontrib><creatorcontrib>Saltsman, W S</creatorcontrib><creatorcontrib>Liscovitch, M</creatorcontrib><creatorcontrib>MacLaughlin, D T</creatorcontrib><creatorcontrib>Donahoe, P K</creatorcontrib><creatorcontrib>Blusztajn, J K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hudson, P L</au><au>Pedersen, W A</au><au>Saltsman, W S</au><au>Liscovitch, M</au><au>MacLaughlin, D T</au><au>Donahoe, P K</au><au>Blusztajn, J K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1994-08-26</date><risdate>1994</risdate><volume>269</volume><issue>34</issue><spage>21885</spage><epage>21890</epage><pages>21885-21890</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing
putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma
A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet
within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter
Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to
sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine
(10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations
in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine,
sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations
of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine
immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine
content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein
was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with
both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may
constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation
of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects.</abstract><cop>United States</cop><pub>American Society for Biochemistry and Molecular Biology</pub><pmid>8063833</pmid><doi>10.1016/S0021-9258(17)31885-9</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 1994-08, Vol.269 (34), p.21885-21890 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_proquest_miscellaneous_76675207 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Calcium - metabolism Carcinoma, Squamous Cell - metabolism Epidermal Growth Factor - pharmacology Humans Phosphorylation Protein-Serine-Threonine Kinases - metabolism Protein-Tyrosine Kinases - metabolism Second Messenger Systems - drug effects Sphingolipids - pharmacology Sphingosine - pharmacology Tumor Cells, Cultured |
title | Modulation by sphingolipids of calcium signals evoked by epidermal growth factor |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T20%3A01%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20by%20sphingolipids%20of%20calcium%20signals%20evoked%20by%20epidermal%20growth%20factor&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Hudson,%20P%20L&rft.date=1994-08-26&rft.volume=269&rft.issue=34&rft.spage=21885&rft.epage=21890&rft.pages=21885-21890&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1016/S0021-9258(17)31885-9&rft_dat=%3Cproquest_cross%3E76675207%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16626824&rft_id=info:pmid/8063833&rfr_iscdi=true |